Lisinopril Tablets for Hypertension
Start lisinopril at 10 mg once daily for most adults with hypertension, titrating to 20-40 mg daily as needed to achieve blood pressure control. 1
Initial Dosing
For adults with uncomplicated hypertension:
- Standard starting dose: 10 mg once daily 1
- Usual maintenance range: 20-40 mg once daily
- Maximum studied dose: 80 mg daily (though doses above 40 mg show minimal additional benefit)
For adults already on diuretics:
- Start at 5 mg once daily to minimize risk of hypotension 1
- May increase after assessing tolerance
For patients with renal impairment:
- CrCl >30 mL/min: No adjustment needed
- CrCl 10-30 mL/min: Start at 5 mg once daily
- CrCl <10 mL/min or hemodialysis: Start at 2.5 mg once daily 1
Titration Strategy
Adjust dose based on blood pressure response, typically every 2-4 weeks until target is achieved. The 2020 ISH guidelines recommend achieving blood pressure control within 3 months 2. If blood pressure remains uncontrolled on lisinopril monotherapy, add a low-dose thiazide diuretic (hydrochlorothiazide 12.5 mg) rather than pushing lisinopril to maximum doses 1.
Combination Therapy Approach
For stage 2 hypertension (BP ≥140/90 mmHg), initiate combination therapy from the start rather than monotherapy 3, 4. The preferred combinations per current guidelines are:
- Non-Black patients: ACE inhibitor (lisinopril) + calcium channel blocker OR thiazide diuretic 2
- Black patients: Calcium channel blocker + thiazide diuretic as first-line (ACE inhibitors less effective as monotherapy in this population) 2
Single-pill combinations are strongly preferred over separate pills to improve adherence 3, 4.
Blood Pressure Targets
Target systolic BP of 120-129 mmHg in most adults per the most recent 2025 AHA/ACC and 2024 ESC guidelines 5, 4. The 2020 ISH guidelines suggest a target of <130/80 mmHg, with individualization for elderly patients based on frailty 2.
For patients who cannot tolerate achieving 120-129 mmHg systolic, target "as low as reasonably achievable" (ALARA principle) 4.
Monitoring Parameters
Monitor the following at baseline and during titration:
- Blood pressure: Measure at each visit until controlled, then every 3-6 months
- Serum creatinine and potassium: Check within 1-2 weeks after initiation or dose increase, then periodically
- Renal function (eGFR): Particularly important in patients with baseline renal impairment 1
Key monitoring timepoints:
- 2-4 weeks after initiation or dose change
- Achieve target BP within 3 months 2
- Once stable, monitor every 3-6 months
Absolute Contraindications
Do not use lisinopril in:
- Pregnancy (all trimesters - causes fetal harm) 6
- History of angioedema with ACE inhibitors or hereditary/idiopathic angioedema
- Bilateral renal artery stenosis or stenosis in a solitary kidney 5
- Concurrent use with aliskiren in patients with diabetes 3
- Combination with ARB + ACE inhibitor (increased risk of hypotension, hyperkalemia, renal dysfunction) 3
Relative Contraindications and Cautions
Use with caution in:
- Renal impairment: Dose adjustment required; monitor creatinine and potassium closely 6, 1
- Peripheral vascular disease: Associated with renovascular disease risk 6
- Volume depletion or hypotension: Risk of excessive BP drop, especially first dose 1
- Hyperkalemia: Monitor potassium, especially with concurrent potassium-sparing diuretics, NSAIDs, or potassium supplements
Compelling Indications for ACE Inhibitors
Lisinopril is particularly indicated in patients with:
- Heart failure with reduced ejection fraction 6, 7
- Post-myocardial infarction with LV dysfunction 6, 7
- Type 1 diabetic nephropathy 6
- Type 2 diabetic nephropathy 6
- Chronic kidney disease with proteinuria 6
For post-MI patients, start lisinopril 5 mg within 24 hours of symptom onset (or 2.5 mg if systolic BP 100-120 mmHg), titrating to 10 mg daily for at least 6 weeks 7, 1.
Special Populations
Pediatric patients (≥6 years):
- Starting dose: 0.07 mg/kg once daily (maximum 5 mg)
- Maximum: 0.61 mg/kg once daily (up to 40 mg)
- Not recommended in children <6 years or with GFR <30 mL/min/1.73m² 1
Elderly patients:
- Same starting dose as younger adults (10 mg) unless frail
- Consider monotherapy in patients >80 years or frail 2
- Individualize BP targets based on frailty status
Common Pitfalls to Avoid
- Starting too high in volume-depleted patients: Always assess volume status; consider 5 mg starting dose if on diuretics
- Not checking renal function and potassium early: Check within 1-2 weeks of initiation, especially in elderly or those with baseline renal impairment
- Combining with ARBs: This combination increases harm without additional benefit 3
- Inadequate titration: Many patients remain on subtherapeutic doses; titrate to effect
- Ignoring race-based differences: ACE inhibitors are less effective as monotherapy in Black patients; start with combination therapy 2
Dosing Frequency Considerations
While the FDA label recommends once-daily dosing 1, one small retrospective study suggested twice-daily dosing (20 mg BID vs 40 mg once daily) may provide greater systolic BP reduction 8. However, a larger study found no effectiveness difference between BID and once-daily dosing 9. Given the lack of robust evidence and the adherence benefits of once-daily dosing, maintain once-daily administration as standard practice unless specific circumstances warrant BID dosing.